Chemfab Alkalis Ltd
Incorproated in 2009, Chemfab
Alkalis Ltd manufactures basic
inorganic chemicals and PVCO
pipes[1]
- Market Cap ₹ 1,210 Cr.
- Current Price ₹ 843
- High / Low ₹ 1,230 / 500
- Stock P/E
- Book Value ₹ 265
- Dividend Yield 0.15 %
- ROCE 3.33 %
- ROE -0.96 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 3.19 times its book value
- Promoter holding has decreased over last quarter: -0.39%
- The company has delivered a poor sales growth of 10.3% over past five years.
- Company has a low return on equity of 8.15% over last 3 years.
- Working capital days have increased from 17.9 days to 67.0 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
205 | 181 | 272 | 331 | 327 | 334 | |
149 | 157 | 215 | 221 | 273 | 291 | |
Operating Profit | 55 | 24 | 57 | 111 | 55 | 44 |
OPM % | 27% | 13% | 21% | 33% | 17% | 13% |
-0 | 1 | 6 | 2 | 9 | -3 | |
Interest | 4 | 3 | 1 | 1 | 2 | 5 |
Depreciation | 25 | 20 | 22 | 23 | 22 | 36 |
Profit before tax | 27 | 2 | 39 | 89 | 39 | -0 |
Tax % | 5% | 500% | 26% | 28% | 33% | 2,210% |
25 | -8 | 29 | 65 | 26 | -7 | |
EPS in Rs | 18.26 | -5.78 | 20.34 | 45.54 | 18.50 | -4.83 |
Dividend Payout % | 7% | 0% | 6% | 3% | 7% | -26% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | 7% |
TTM: | 2% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -115% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 48% |
3 Years: | 64% |
1 Year: | 38% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 7% |
3 Years: | 8% |
Last Year: | -1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 |
Reserves | 262 | 253 | 284 | 347 | 373 | 366 |
43 | 32 | 9 | 2 | 20 | 84 | |
30 | 36 | 46 | 48 | 93 | 58 | |
Total Liabilities | 348 | 335 | 352 | 412 | 500 | 522 |
195 | 202 | 194 | 192 | 247 | 317 | |
CWIP | 35 | 3 | 8 | 31 | 74 | 36 |
Investments | 1 | 24 | 31 | 68 | 5 | 16 |
118 | 105 | 119 | 121 | 174 | 152 | |
Total Assets | 348 | 335 | 352 | 412 | 500 | 522 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
54 | 45 | 55 | 93 | 31 | 40 | |
-58 | -6 | -21 | -48 | -110 | -86 | |
3 | -16 | -25 | -9 | 16 | 59 | |
Net Cash Flow | -1 | 23 | 9 | 36 | -62 | 13 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 17 | 31 | 29 | 24 | 24 | 23 |
Inventory Days | 84 | 79 | 54 | 89 | 60 | 100 |
Days Payable | 165 | 154 | 92 | 145 | 101 | 118 |
Cash Conversion Cycle | -63 | -45 | -9 | -32 | -18 | 4 |
Working Capital Days | 23 | 31 | 14 | 8 | -21 | 67 |
ROCE % | 2% | 13% | 28% | 10% | 3% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 May - Dear Sir/Madam, Please find the attached Copy of Newspaper publication of Audited financial results for the quarter and year ended 31.03.2025
-
Announcement under Regulation 30 (LODR)-Investor Presentation
15 May - Dear Sir/madam, Please find the attached investor presentation for the quarter and year ended on 31st March, 2025
- Corporate Action-Board approves Dividend 14 May
- Declaration With Respect To The Audit Report With Unmodified Opinion To The Audited Financial Results For The Financial Year Ended 31St March 2025 14 May
-
Announcement under Regulation 30 (LODR)-Change in Management
14 May - Approved FY25 results with unmodified opinion; recommended Rs.1.25/share final dividend; appointed auditors for FY26.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
May 2025TranscriptNotesPPT
Business Overview:[1][2]
CAL is an ISO 14001 and OHSAS 18001 certified manufacturer of choloro alkali products. It uses Membrane Technology for Chloralkali production. Company also produces chlorine, hydrogen, sodium hypo chlorite, and hydrochloric acid as by-products from manufacture of caustic soda